Kraig Biocraft Laboratories Inc. (KBLB) Financials
Post# of 250675
Posted On: 11/17/2014 2:39:04 AM
Kraig Biocraft Laboratories Inc. (KBLB) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Kraig Biocraft Laboratories Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 0 234,011 215,370 - -
COGS excluding D&A 0 233,558 210,000 - -
Depreciation & Amortization Expense 0 453 5,370 5,583 5,888
Depreciation - 453 5,370 5,583 5,888
Amortization of Intangibles - 0 0 0 0
Gross Income 0 (234,011) (215,370) - -
2009 2010 2011 2012 2013 5-year trend
SG&A Expense - 959,821 1.08M 1.55M 2.28M
Research & Development - 141,310 250,598 465,293 489,434
Other SG&A - 818,511 831,442 1.09M 1.79M
Other Operating Expense - 0 0 0 0
Unusual Expense - 444,078 0 - 5.18M
EBIT after Unusual Expense - (444,078) 0 - (5.18M)
Non Operating Income/Expense - 0 2,100 3,000 0
Non-Operating Interest Income - - - 192 47
Equity in Affiliates (Pretax) - 0 0 0 0
Interest Expense 41,814 144,978 0 45,707 0
Gross Interest Expense 41,814 144,978 0 45,707 0
Interest Capitalized - 0 0 0 0
Pretax Income (1.43M) (1.78M) (1.3M) (1.6M) (7.47M)
Income Tax - 0 0 0 0
Income Tax - Current Domestic - 0 0 - -
Income Tax - Current Foreign - 0 0 - -
Income Tax - Deferred Domestic - 0 0 - -
Income Tax - Deferred Foreign - 0 0 - -
Income Tax Credits - 0 0 - -
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income (1.43M) (1.78M) (1.3M) (1.6M) (7.47M)
Minority Interest Expense - 0 0 0 0
Net Income (1.43M) (1.78M) (1.3M) (1.6M) (7.47M)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries (1.43M) (1.78M) (1.3M) (1.6M) (7.47M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common - (1.78M) (1.3M) (1.6M) (7.47M)
EPS (Basic) 0.00 0.00 0.00 () (0.01)
Basic Shares Outstanding 504.12M 401.59M 572.71M 596.14M 616.31M
EPS (Diluted) 0.00 0.00 0.00 () (0.01)
Diluted Shares Outstanding 504.12M 401.59M 572.71M 596.14M 616.31M
EBITDA - (1.19M) (1.29M) (1.55M) (2.28M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Kraig Biocraft Laboratories Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 0 234,011 215,370 - -
COGS excluding D&A 0 233,558 210,000 - -
Depreciation & Amortization Expense 0 453 5,370 5,583 5,888
Depreciation - 453 5,370 5,583 5,888
Amortization of Intangibles - 0 0 0 0
Gross Income 0 (234,011) (215,370) - -
2009 2010 2011 2012 2013 5-year trend
SG&A Expense - 959,821 1.08M 1.55M 2.28M
Research & Development - 141,310 250,598 465,293 489,434
Other SG&A - 818,511 831,442 1.09M 1.79M
Other Operating Expense - 0 0 0 0
Unusual Expense - 444,078 0 - 5.18M
EBIT after Unusual Expense - (444,078) 0 - (5.18M)
Non Operating Income/Expense - 0 2,100 3,000 0
Non-Operating Interest Income - - - 192 47
Equity in Affiliates (Pretax) - 0 0 0 0
Interest Expense 41,814 144,978 0 45,707 0
Gross Interest Expense 41,814 144,978 0 45,707 0
Interest Capitalized - 0 0 0 0
Pretax Income (1.43M) (1.78M) (1.3M) (1.6M) (7.47M)
Income Tax - 0 0 0 0
Income Tax - Current Domestic - 0 0 - -
Income Tax - Current Foreign - 0 0 - -
Income Tax - Deferred Domestic - 0 0 - -
Income Tax - Deferred Foreign - 0 0 - -
Income Tax Credits - 0 0 - -
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income (1.43M) (1.78M) (1.3M) (1.6M) (7.47M)
Minority Interest Expense - 0 0 0 0
Net Income (1.43M) (1.78M) (1.3M) (1.6M) (7.47M)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries (1.43M) (1.78M) (1.3M) (1.6M) (7.47M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common - (1.78M) (1.3M) (1.6M) (7.47M)
EPS (Basic) 0.00 0.00 0.00 () (0.01)
Basic Shares Outstanding 504.12M 401.59M 572.71M 596.14M 616.31M
EPS (Diluted) 0.00 0.00 0.00 () (0.01)
Diluted Shares Outstanding 504.12M 401.59M 572.71M 596.14M 616.31M
EBITDA - (1.19M) (1.29M) (1.55M) (2.28M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)